PCRX vs. SAH
PCRX (Pacira BioSciences, Inc.) and SAH (Sonic Automotive, Inc.) are both stocks. PCRX operates in Drug Manufacturers - Specialty & Generic (Healthcare), while SAH operates in Auto & Truck Dealerships (Consumer Cyclical). Over the past 10 years, PCRX returned -7.19%/yr vs 19.21%/yr for SAH. At a 0.23 correlation, their price movements are largely independent.
Performance
PCRX vs. SAH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PCRX achieves a -13.76% return, which is significantly lower than SAH's 35.49% return. Over the past 10 years, PCRX has underperformed SAH with an annualized return of -7.19%, while SAH has yielded a comparatively higher 19.21% annualized return.
PCRX
- 1D
- 0.31%
- 1M
- -9.60%
- YTD
- -13.76%
- 6M
- -7.73%
- 1Y
- -15.45%
- 3Y*
- -17.04%
- 5Y*
- -18.20%
- 10Y*
- -7.19%
SAH
- 1D
- -1.78%
- 1M
- 10.19%
- YTD
- 35.49%
- 6M
- 31.25%
- 1Y
- 19.85%
- 3Y*
- 26.86%
- 5Y*
- 14.13%
- 10Y*
- 19.21%
PCRX vs. SAH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PCRX Pacira BioSciences, Inc. | -13.76% | 37.37% | -44.16% | -12.61% | -35.83% | 0.55% | 32.10% | 5.30% | -5.76% | 41.33% |
SAH Sonic Automotive, Inc. | 35.49% | -0.27% | 15.18% | 16.72% | 1.93% | 29.41% | 26.06% | 129.24% | -24.45% | -18.62% |
Correlation
The correlation between PCRX and SAH is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.22 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.21 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.22 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.23 |
Correlation (All Time) Calculated using the full available price history since Feb 4, 2011 | 0.23 |
Fundamentals
PCRX:
$913.11M
SAH:
$2.83B
PCRX:
$0.21
SAH:
$3.17
PCRX:
104.26
SAH:
26.31
PCRX:
1.32
SAH:
0.19
PCRX:
1.40
SAH:
2.89
PCRX:
$734.86M
SAH:
$15.19B
PCRX:
$427.72M
SAH:
$2.25B
PCRX:
$95.04M
SAH:
$517.70M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PCRX vs. SAH — Risk / Return Rank
PCRX
SAH
PCRX vs. SAH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Pacira BioSciences, Inc. (PCRX) and Sonic Automotive, Inc. (SAH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PCRX | SAH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.92 | ||
| Sortino ratioReturn per unit of downside risk | -1.26 | ||
| Omega ratioGain probability vs. loss probability | 0.96 | 1.12 | -0.17 |
| Calmar ratioReturn relative to maximum drawdown | -0.52 | 0.59 | -1.12 |
| Martin ratioReturn relative to average drawdown | -1.07 | 0.94 | -2.01 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| PCRX | SAH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.42 | 0.50 | -0.92 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.40 | 0.34 | -0.74 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.15 | 0.41 | -0.56 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.16 | 0.20 | -0.04 |
Drawdowns
PCRX vs. SAH - Drawdown Comparison
The maximum PCRX drawdown since its inception was -90.19%, smaller than the maximum SAH drawdown of -97.17%. Use the drawdown chart below to compare losses from any high point for PCRX and SAH.
Loading charts...
Drawdown Indicators
| PCRX | SAH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -90.19% | -97.17% | +6.98% |
Max Drawdown (1Y)Largest decline over 1 year | -29.61% | -33.64% | +4.03% |
Max Drawdown (3Y)Largest decline over 3 years | -71.53% | -33.64% | -37.89% |
Max Drawdown (5Y)Largest decline over 5 years | -85.67% | -37.97% | -47.70% |
Max Drawdown (10Y)Largest decline over 10 years | -85.67% | -70.80% | -14.87% |
Current DrawdownCurrent decline from peak | -81.29% | -4.56% | -76.73% |
Average DrawdownAverage peak-to-trough decline | -50.01% | -34.10% | -15.91% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.42% | 21.20% | -6.78% |
Volatility
PCRX vs. SAH - Volatility Comparison
The current volatility for Pacira BioSciences, Inc. (PCRX) is 10.03%, while Sonic Automotive, Inc. (SAH) has a volatility of 11.80%. This indicates that PCRX experiences smaller price fluctuations and is considered to be less risky than SAH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PCRX | SAH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.03% | 11.80% | -1.77% |
Volatility (6M)Calculated over the trailing 6-month period | 28.70% | 25.54% | +3.16% |
Volatility (1Y)Calculated over the trailing 1-year period | 37.03% | 39.52% | -2.49% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 45.60% | 41.92% | +3.68% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 46.90% | 47.53% | -0.63% |
Dividends
PCRX vs. SAH - Dividend Comparison
PCRX has not paid dividends to shareholders, while SAH's dividend yield for the trailing twelve months is around 1.79%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PCRX Pacira BioSciences, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SAH Sonic Automotive, Inc. | 1.79% | 2.36% | 1.97% | 2.06% | 2.09% | 0.93% | 1.04% | 1.29% | 1.74% | 1.08% | 0.87% | 0.49% |
Financials
PCRX vs. SAH - Financials Comparison
This section allows you to compare key financial metrics between Pacira BioSciences, Inc. and Sonic Automotive, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
PCRX vs. SAH - Profitability Comparison
PCRX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Pacira BioSciences, Inc. reported a gross profit of 0.00 and revenue of 177.38M. Therefore, the gross margin over that period was 0.0%.
SAH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Sonic Automotive, Inc. reported a gross profit of 560.10M and revenue of 3.69B. Therefore, the gross margin over that period was 15.2%.
PCRX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Pacira BioSciences, Inc. reported an operating income of 6.90M and revenue of 177.38M, resulting in an operating margin of 3.9%.
SAH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Sonic Automotive, Inc. reported an operating income of 133.10M and revenue of 3.69B, resulting in an operating margin of 3.6%.
PCRX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Pacira BioSciences, Inc. reported a net income of 7.08M and revenue of 177.38M, resulting in a net margin of 4.0%.
SAH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Sonic Automotive, Inc. reported a net income of 60.80M and revenue of 3.69B, resulting in a net margin of 1.7%.
Frequently Asked Questions
PCRX and SAH have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SAH has higher volatility (11.80%) compared to PCRX (10.03%). In terms of maximum drawdown, PCRX dropped -90.19% vs SAH's -97.17%.
SAH currently has the higher Sharpe Ratio (0.50 vs -0.42), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PCRX and SAH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer